Viewing Study NCT04380103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2026-02-23 @ 9:20 AM
Study NCT ID: NCT04380103
Status: UNKNOWN
Last Update Posted: 2020-05-08
First Post: 2020-05-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer
Sponsor: Chinese Academy of Medical Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Cancer View
None Colorectal Cancer View
None Colorectal Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic colorectal cancer View
None metastatic colorectal adenocarcinoma View
None XELOXIRI View
None bevacizumab View